🏢 Company
Ligand Pharmaceuticals
American Pharmaceutical Company
📊 Rating
2 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Corporate Finance (1)
- Executive Actions (1)
- Corporate Governance (1)
- Financial Markets (1)
🏷️ Keywords
Ligand Pharmaceuticals (2) · insider trading (2) · regulatory filing (2) · CFO (1) · stock sale (1) · shares (1) · executive compensation (1) · CLO (1) · share sale (1)
📖 Key Information
Ligand Pharmaceuticals is an American biopharmaceutical company that focuses on acquiring and developing royalty-generating assets. As of 2024, the company's portfolio included royalty rights to approximately 90 pharmaceutical products across a range of therapeutic areas. Notable products from which Ligand receives royalties include the multiple myeloma (cancer) treatments Kyprolis and Evomela, the kidney disease therapy Filspari, and the pneumococcal vaccine Vaxneuvance.
📰 Related News (2)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Ligand Pharmaceuticals:
-
🌐
CLO · 1 shared articles
-
🏢
Chief financial officer · 1 shared articles